chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt recv vax 5JUN96 & 10JUN96 pt exp rash on face & arms w/more than 20 lesions;12JUN96 pt returned to MD office w/a t104;@ that time the rash had spread all over body in red, patchy papules;tx w/APAP for fever;
Pt was administered Hib and PCV vaccines in thigh. Pt way crying following administration of first vaccine (Hib). Immediately after the second vaccine (PCV) was administered (while I, the administrator of the vaccine was applying a bandage), the patient stopped crying and the parents became alarmed and stated that patient was not breathing. The patient's face appeared dusky and red. The patient's eyes then rolled up and the patient arched her back. I was unable to determine if the patient had, indeed, stopped breathing as the patient's father picked up the infant and began blowing on her face. Within seconds, the patient began crying again. The entire episode lasted less than 1 minute. The patient was examined following the incident and, while clearly frightened, appeared stable.
PATIENT RECEIVED FIRST DOSE OF PFIZER ON 12/22/2020. PATIENT RECEIVED SECOND DOSE 252 DAYS AFTER FIRST DOSE.
Pt developed urticarial Type rash on injection site then spread to cover entire body. No associated fever at time of rash but did have subject fever 24 hours prior, + pruritus.
partial loss of consciousness approx 10 minutes after vaccination; Dizziness, faintness; General feeling of unwellness; partial loss of vision; This is a spontaneous report from a contactable consumer (patient). A 36-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 07Mar2021 at 10:30 (batch/lot number: unknown) as a single dose for COVID-19 immunisation. Medical history included allergy to penicillin. The patient's concomitant medications were not reported. The patient previously took ofloxacin and experienced allergy. No other vaccine in four weeks. No Covid prior to vaccination and was not Covid tested post vaccination. The patient experienced dizziness, faintness. Partial loss of vision, partial loss of consciousness approx. 10 minutes after vaccination (07Mar2021 10:40). General feeling of unwellness following. The events were reported as started on an unspecified date in Mar2021 11:00. No treatment was received for the events. The outcome of the events was recovering.   Information on lot/batch number has been requested.
day p/vax arm swelled, & red w/welt 3/4 the way around arm;hot to touch, pain shoulder & neck;lasted for 1wk;states it was arm in which pneumovax was given;
Massive headache; Severe chills; Couldn't get warm all day even with multiple layers of clothing; Dizziness/lightheaded; Feverish; Going from freezing cold to sweating profusely; Right arm is really itchy; Place on right arm started out as a red blotch the size of a nickel, but today is as big around as a grapefruit; This is a spontaneous report from a contactable consumer (patient). A 55-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL3302; Expiration date was not reported) on 16Jan2021 (17:30) at a single dose on the right arm, with route of administration unspecified, for COVID-19 immunization. The patient had no relevant medical history and concomitant medications. The patient had previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL0140; Expiration date was not reported) on 30Dec2020 (when the patient was 55 years old) on the left arm for COVID-19 immunization. The patient had no issues with the first dose of vaccination. On 17Jan2021, the morning after the second dose of vaccination, the patient woke up with a massive headache; developed severe chills; could not get warm all day long even with multiple layers of clothing; was dizzy and lightheaded; feverish; was freezing cold one minute, and then sweating profusely the next; right arm was really itchy; and had red blotch that was as big as a nickel, then as big around as a grapefruit at the time of reporting. The outcome of the events was recovered on 19Jan2021 for 'massive headache', 'could not get warm all day long even with multiple layers of clothing' and 'dizziness/lightheaded'; was recovering for 'severe chills', 'feverish' and 'freezing cold one minute, and then sweating profusely the next'; was not recovered for 'right arm was really itchy' and 'red blotch that was as big as a nickel, then as big around as a grapefruit'.
I thought I was experiencing allergies induced asthma. By Saturday morning I was still having breathing problems. I went to the urgent care, and they tested me for COVID-19 and, I was positive. They prescribed me prednisone for my asthma symptoms and for the COVID-19 remdesivir infusion for 3 days. My symptoms got better after infusion.
Patient with dizziness, hot arm, sore throat. He was administered Benadryl 25mg and IV fluids
Complaints of fever, tachycardia after vaccination,myalgias, chest ache, axillary adenopathy and tenderness.
Night of/Day after patient developed rash, swelling, and pain in arm. Went to walk-in and given Keflex on 10/8/19
Client  received the COVID vaccine (Pfizer dose 1, lot # EW0187, expiration date 7/12/2021) in his left deltoid at 1835. The client reported to RN at 1705 that he was experiencing itching. RN  informed EMT and RN , who responded at that time. The client stated that the itching had started "5 minutes" after he was vaccinated and he was experiencing itching on his bilateral upper and lower extremities, as well as the back of his head. The client denied any shortness of breath or chest pain. The client didn't have any observable swelling on his head or tongue, and he had no observable rashes on his extremities or head. The client stated he had a history of hypertension but takes no medications, and he stated that he had an allergy to penicillin. The client stated that he last ate at noon. At 1710, the client's vital signs were as follows: blood pressure 158/112, heart rate 76, respiratory rate 18, O2 97%. The client stated he did not know his usual blood pressure range. The client denied any headache and his pulses were normal. The client stated that he was feeling "heat"; the client's skin was pink, warm, and dry. The client continued to denied any difficulty breathing. The client was alert and oriented x4. The client was offered water and oral Benadryl (50 mg) at 1710, which he accepted. At 1720, the client's vital signs were as follows: blood pressure 152/102, heart rate 74, O2 96%. The client stated that the itching had stayed the same. Education provided to the client and his partner regarding emergency management, primary care follow up, and v-safe. At 1730, the client's vital signs were as follows: blood pressure 150/96, heart rate 78, O2 95%. At 1735, the client stated that his symptoms of itching and heat had resolved. The client was sitting in his chair comfortably resting. At 1740, the client was able to stand without dizziness, and ambulated with a steady gait out to his car, where his partner drove him home.
pt c/o having redness & pain @ the site of inj;vax given 9MAY97;also c/o having fever of up to 103;feeling achy all over;nauseated;erythema about 15mm in diameter;warm & tender to touch;serum sickness rxn;
Woke up in AM on 09/02/15 with numbness in left hand/thumb. That night had numbness in right leg. On 09/04/15 had numbness in right hand with H/A and burning sensation on head. All symptoms gone by 09/07/15.
On 10/2/2022 my symptoms were draining into my throat, a bit of a cough, and later in the day congestion and body aches. I took a COVID-19 home test on 10/2/2022 and it was negative. The next day, 10/3/2022, I felt worse, and I tested again, and it was positive. I had a fever, chest congestion, stomach upset, and fatigue. I sent my doctor a message on 10/3/2022 that I had tested positive, and she said she wanted to do a video call with me on 10/4/2022. The doctor felt that I had a lot of symptoms, and she was going to put me on PAXLOVID. But because of my liver problems she decided that was not a good medication to take. So, she prescribed molnupiravir. I started taking the medication on 10/4 in the evening and I took the last dose on the morning of 10/9. When I stopped taking the medication my symptoms had decreased. I tested on 10/10/22 and the results were negative. Then I had a rebound, I tested positive on 10/11/2022 and the results were positive. Today, 10/14/2022 I have a congestion and a little bit of a cough and fatigue, and I tend to have an upset stomach.
Incorrect pfizer vaccine administered. Patient is 12, I administered the 5-11 year old vaccine because the vial says "5 to < 12" instead of "5 to 11" and looks like it says "5 to 12".
Patient reported multiple irritated areas about 1-2 inches away from the injection site on the right arm. She took BENADRYL and placed ice on the area. She has not reported back since our last conversation to inform me of any further problems or complications.
Pt. called and stated she got a bacterial infection from the vaccine she received on 4/16/13.
Crops of petechiae both legs.  New lesions still appearing 2 months later, increased with crying.
Approximately 3 days after vaccine pt's arm became red about 3-4 cm. around injection site. Gradually grew to a red spot approximately 3 1/2 to 4 inches around the site and became painful. As of 8/23/15 redness has gone down a little but arm began to peel a large area below site.
This case was reported by a physician via sales rep and described the occurrence of febrile seizure in a patient who received KINRIX. On an unknown date, the patient received KINRIX at an unknown dose. On an unknown date, an unknown time after receiving KINRIX, the patient experienced febrile seizure (serious criteria GSK medically significant). On an unknown date, the outcome of the febrile seizure was unknown. It was unknown if the reporter considered the febrile seizure to be related to KINRIX. Additional details were provided as follows: The reporter reviewed KINRIX product information (PI) and asked if Medical Science Liaison (MSL) could assist this case. The sales representative reviewed BOOSTRIX with adult provider and gain commitment that history of Tdap was reviewed and asked on appropriate patients.
2-3 minutues after the administration of vaccine, I entered the room after hearing parent calling out patient's name.  On initial observation after entering the room and trying to talk to the patient, he was noted to be having generalized tonic clonic movement with unfocused glance. But wihtin seconds the movements stopped, and he was able to focus on my face and answer my questions. He was talking in his usual voice (with no slurring), and was oriented to person, time, and place. He had normal neurological exam. Vitals (BP 110/61; HR 70; R-18; SpO2 96%; T-98.1). With in a few minutes he was smiling and continued to answer all questions appropriately. Patient stated that he felt dizzy and laid down before the episode occurred, and does not remember what happened after, until he started to answer my questions. He was monitored in clinic for next 30min with no other complaints and walked out of the clinic talking and smiling.
Information has been received from a health professional concerning a 7 year old white female who on 11-SEP-2001 was vaccinated with Varivax. On 03-MAY-2006 the patient experienced chickenpox. She had "scattered small (2cm) on a red 4 mm base papular to front of pubic area and lower abdomen and chest." There were a few on the face and arms. It was noted that she was exposed to her grandfather who had shingles two weeks prior. There were no labs done and no treatment was needed. It was reported that the patient recovered. It was unknown if medical attention was sought. Additional information has been requested.
Patient was immunized with monovalent Pfizer vaccine booster dose 0.3ml. Vaccine was administered into the right deltoid by our member. Private was informed to no longer administer monovalent vaccines after the vaccine was given by the clinical team. The bivalent vaccine boosters were authorized on this day.
Moderna CovID-19 vaccine ?about 30 minutes after vaccine I had a flushed feeling and mild dizziness which didn?t last long. Maybe 15-30 min.  ?about 30 min after vaccine I had a pulling/pressure/mild pain in my neck on the same side as the injection site ?about 26 hours after the vaccine I had fever, chills, mild headache, severe muscle pain throughout my whole body and also bone/joint pain. This lasted roughly 6 hours.  About 26 hours after vaccine I had very painful low back pain. This lasted a few days.  ?mild headache for several days ?fatigue several days ?5 days after vaccine mild diarrhea, mild headache, continued fatigue
Patient complained of very red itchy site. Site had small white spot in the center surrounded by red itchy area 4-6mm in size. No pain or swelling. He showed area to his own doctor he was told he should still have the flu shot next year. Patient is concerned he would have an anaphlactic reaction next year. He is a retired Dr. At this time white spot is present redness is getting smaller. All this is as reported by patient.
Hives on arms and chest. States tongue felt 'unusual' for a brief period of time.  Hives resolved with Benadryl.  No swelling of tongue or throat and no difficulty breathing.
Onset of itching to various areas of body with small, but prominent hives to distal right arm, chest, neck.  Onset within 20-25 minutes.  No history of reaction in the past to vaccine, tape, or alcohol rub.  OTC antihistamines and monitor
Patient sent to the ED or sudden onset of shortness of breath on 02/02/2021. Per documentation by the MD, the patient had COVID19 "several weeks ago" and the nursing facility felt like he had recovered. A rapid test done in the ED was negative. When the patient worsened and seemed to be following the same path as other COVID patients, a send out PCR test was done, which was positive. The patient worsened and passed away that same day (02/05/2021) I was not made aware that the patient had the vaccine on 01/21/2021 until Monday 02/08/2021.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 17Dec2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Crohn's disease" (unspecified if ongoing); "known allergies: yes" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: positive. Therapeutic measures were taken as a result of covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Information has been received from a physician concerning "a number of patients" (ages not reported), who were vaccinated with GARDASIL (date, dose and route not reported). No concomitant medications or pertinent medical history were specified. "Physician reported that a number of patients stated that it hurt when receiving GARDASIL. The patients reported this after administration while still in the office. The outcome of the event was not reported. No product quality complaint was involved. No further information is available.
Temperature Excursion Heplisav-B Administered to 15 Patients; Initial Report Received on 14-Sep-2021 and 15-Sep-2021  A Registered Medical Assistant reported that approximately 15 patients (age, gender, race and ethnicity not provided) received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization after the vaccine was out of temperature range with multiple excursions over a maximum of 10 days. This report is for patient 11 of 15.  No relevant medical history was reported.    No relevant concomitant medications were reported.    On an unspecified date, the patient 11 of 15 received a dose of HEPLISAV-B (Lot #, expiration date and NDC # not reported) after the vaccine was out of temperature range with multiple excursions over a maximum of 10 days. The route and site of vaccine administration were not reported.   No additional information was reported.   Company Comment:  The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
Patients still feels pain in arm after 6 days. No redness or swelling, has tried cool, compress, Tylenol, and Ibuprofen. These efforts were did not improve the reaction.
Had sore arm initially. On 3/29 was sitting watching TV when she thought her chest felt bumpy. She looked and had hives all over. She mentioned that it seemed worst where her clothes touched her body.
Information has been received from a registered nurse concerning a 14 year old male with asthma and seasonal allergies who on 15-JAN-1996 was vaccinated with VARIVAX (Merck) (lot # 610248/0446B), 0.5 ml via subcutaneous administration. Concomitant therapy included SYMBICORT, MAXAIR, Montelukast sodium, ZYRTEC and FLONASE. On 15-APR-2008 the patient experienced red pimple like rash, and was afebrile. On 16-APR-2008, he was seen in the office with 30 pustules and diagnosed with chicken pox. He was treated with VALTREX, calamine lotion and antihistamines. At the time of report, the event persisted. The patient's mother reported that other students in his school have also recently experienced chicken pox. Additional information is not expected as the nurse is unable to provide additional details.
The patient complained of a lump at the injection site, pain, muscle weakness and tingling down her left arm the morning after her vaccine.  She treated it with ice and heat.  Her symptom persisted and on day 4 she was seen by employee health and referred to a physician for evaluation and treatment.
I was having fluttering of my heart and I was feel like, It is been stuck; It's just 5 days or a week ago like, I am experiencing it.; This is a spontaneous report from a contactable consumer (patient herself). A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number: EW0186, Expiry date, NDC number, UPC number was not reported), via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had experienced i was having fluttering of my heart and i was feel like, it is been stuck; it's just 5 days or a week ago like, i am experiencing it. Caller stated, I don't see LOT# number on my card. It's my name, my date of birth, first dose. Oh Is the number in box on the card, Started with E. It has some letter in it. It is (#). That's what I see under the word Pfizer. Caller stated, do you have to document because I am asking a question, patient had the question about the Covid vaccine. Patient got the 1st shot and didn't show any reaction, but side effect, when came home, I was having fluttering of my heart and I was feel like, It is been stuck and Is it recommended that, You take the 2nd dose after experience that because the patient did not and had not this qualification so, patient's doctor knows about it. It's just 5 days or a week ago like, patient experiencing it. Caller stated, what is that, No. patient consulted the doctor and they didn't gave any medication. The patient did not receive treatment for the adverse event. The outcome of events was not recovered.  Follow-up attempts are completed. No further information is expected.
stroke; double vision; cannot swallow; vertigo; no vision; could not walk; one side body went numb; headache; vomiting; fell down a few times; dizziness, lightheaded; balance issues; weak; tired; This spontaneous case was reported by a patient family member or friend and describes the occurrence of CEREBROVASCULAR ACCIDENT (stroke) and BLINDNESS TRANSIENT (no vision) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A21A and 012A21A) for COVID-19 immunization. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Fruit allergy (Allergic to Peaches). Concomitant products included MULTIVITAMIN [VITAMINS NOS] and VITAMIN D [VITAMIN D NOS] for an unknown indication.   On 24-Feb-2021 at 9:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021 at 9:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced BALANCE DISORDER (balance issues), ASTHENIA (weak) and FATIGUE (tired). On 26-Mar-2021 at 12:00 PM, the patient experienced DIZZINESS (dizziness, lightheaded). On 27-Mar-2021, the patient experienced FALL (fell down a few times). On 28-Mar-2021, the patient experienced BLINDNESS TRANSIENT (no vision) (seriousness criterion medically significant), GAIT DISTURBANCE (could not walk), HYPOAESTHESIA (one side body went numb), HEADACHE (headache) and VOMITING (vomiting). On 28-Mar-2021 at 10:30 AM, the patient experienced CEREBROVASCULAR ACCIDENT (stroke) (seriousness criterion hospitalization) and VERTIGO (vertigo). On 30-Mar-2021, the patient experienced DIPLOPIA (double vision) and DYSPHAGIA (cannot swallow). The patient was hospitalized on 28-Mar-2021 due to CEREBROVASCULAR ACCIDENT. At the time of the report, CEREBROVASCULAR ACCIDENT (stroke), DIPLOPIA (double vision), DYSPHAGIA (cannot swallow), VERTIGO (vertigo), GAIT DISTURBANCE (could not walk), HYPOAESTHESIA (one side body went numb) and HEADACHE (headache) had not resolved, BLINDNESS TRANSIENT (no vision) and FALL (fell down a few times) had resolved and DIZZINESS (dizziness, lightheaded), BALANCE DISORDER (balance issues), ASTHENIA (weak), FATIGUE (tired) and VOMITING (vomiting) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Mar-2021, Blood pressure measurement: 270/150 mmHg. On 30-Mar-2021, Magnetic resonance imaging: abnormal MRI showed stroke in cerebellum- left medulla part of brain.; Sender's Comments: Very limited information regarding these events has been provided at this time. The events are probably related to the patient's comorbidities
(1) Muscle aches for 6 months after booster (2) Joint pain and swelling for 1 year after booster (3) Intermittent rapid heart rate or palpitations for 18 months after booster